
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5397412
[patent_doc_number] => 20090317475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'COMBINATION ANTITUMOR THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/160091
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2487
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317475.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160091 | COMBINATION ANTITUMOR THERAPIES | Jan 2, 2007 | Abandoned |
Array
(
[id] => 204017
[patent_doc_number] => 07628990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/647878
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26919
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/628/07628990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11647878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/647878 | Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof | Dec 28, 2006 | Issued |
Array
(
[id] => 5409576
[patent_doc_number] => 20090123474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/097384
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17427
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123474.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097384 | COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER | Dec 11, 2006 | Abandoned |
Array
(
[id] => 5247799
[patent_doc_number] => 20070244033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/608706
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30858
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11608706
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/608706 | METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5563662
[patent_doc_number] => 20090136514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Tetracyclines for Treating Ocular Diseases and Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/086146
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9651
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136514.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086146
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086146 | Tetracyclines for Treating Ocular Diseases and Disorders | Dec 6, 2006 | Abandoned |
Array
(
[id] => 5119252
[patent_doc_number] => 20070140966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Multivalent immunoglobulin-based bioactive assemblies'
[patent_app_type] => utility
[patent_app_number] => 11/633729
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 50239
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20070140966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11633729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/633729 | Multivalent immunoglobulin-based bioactive assemblies | Dec 4, 2006 | Issued |
Array
(
[id] => 5062555
[patent_doc_number] => 20070224194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/566195
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22454
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224194.pdf
[firstpage_image] =>[orig_patent_app_number] => 11566195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/566195 | Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis | Nov 30, 2006 | Abandoned |
Array
(
[id] => 5342366
[patent_doc_number] => 20090181016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME'
[patent_app_type] => utility
[patent_app_number] => 12/095493
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19891
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095493 | FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME | Nov 29, 2006 | Abandoned |
Array
(
[id] => 10031497
[patent_doc_number] => 09072797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies'
[patent_app_type] => utility
[patent_app_number] => 12/097508
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 11
[patent_no_of_words] => 9103
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12097508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097508 | Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies | Nov 29, 2006 | Issued |
Array
(
[id] => 5159379
[patent_doc_number] => 20070172423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Composition and method for modulating vasculogenesis for angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/605607
[patent_app_country] => US
[patent_app_date] => 2006-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 28136
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172423.pdf
[firstpage_image] =>[orig_patent_app_number] => 11605607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/605607 | Composition and method for modulating vasculogenesis for angiogenesis | Nov 28, 2006 | Abandoned |
Array
(
[id] => 4792662
[patent_doc_number] => 20080293636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Protein Constructs Designed for Targeting and Lysis of Cells'
[patent_app_type] => utility
[patent_app_number] => 12/094877
[patent_app_country] => US
[patent_app_date] => 2006-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8052
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293636.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094877
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094877 | Protein constructs designed for targeting and lysis of cells | Nov 22, 2006 | Issued |
Array
(
[id] => 5278580
[patent_doc_number] => 20090130712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Compositions and Methods of Producing Hybrid Antigen Binding Molecules and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/085155
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 25432
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130712.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085155 | Compositions and methods of producing hybrid antigen binding molecules and uses thereof | Nov 20, 2006 | Issued |
Array
(
[id] => 5252803
[patent_doc_number] => 20070134259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Methods and compositions for pharmacologially controlled targeted immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/602493
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6870
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134259.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602493 | Methods and compositions for pharmacologially controlled targeted immunotherapy | Nov 20, 2006 | Abandoned |
Array
(
[id] => 281487
[patent_doc_number] => 07553486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Anti-VEGF treatment for radiation-induced vasculopathy'
[patent_app_type] => utility
[patent_app_number] => 11/598302
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3324
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11598302
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/598302 | Anti-VEGF treatment for radiation-induced vasculopathy | Nov 12, 2006 | Issued |
Array
(
[id] => 4492146
[patent_doc_number] => 07955807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Method of measuring PTX3 with high sensitivity'
[patent_app_type] => utility
[patent_app_number] => 12/092272
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13327
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/955/07955807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092272
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092272 | Method of measuring PTX3 with high sensitivity | Nov 9, 2006 | Issued |
Array
(
[id] => 4759378
[patent_doc_number] => 20080311604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/091899
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6846
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311604.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091899 | Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy | Oct 31, 2006 | Abandoned |
Array
(
[id] => 5545973
[patent_doc_number] => 20090155850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Horse:Human Chimeric Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/090166
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16611
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155850.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090166
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090166 | Horse:Human Chimeric Antibodies | Oct 26, 2006 | Abandoned |
Array
(
[id] => 560511
[patent_doc_number] => 07470773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Immunoglobulin E detection in mammalian species'
[patent_app_type] => utility
[patent_app_number] => 11/585712
[patent_app_country] => US
[patent_app_date] => 2006-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3304
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11585712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/585712 | Immunoglobulin E detection in mammalian species | Oct 23, 2006 | Issued |
Array
(
[id] => 5119351
[patent_doc_number] => 20070141065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Anti-VEGF antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/583994
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 53346
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141065.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583994
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583994 | Anti-VEGF antibodies | Oct 18, 2006 | Issued |
Array
(
[id] => 5022214
[patent_doc_number] => 20070148180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Peptide-immunoglobulin-conjugate'
[patent_app_type] => utility
[patent_app_number] => 11/583547
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13314
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148180.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583547
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583547 | Peptide-immunoglobulin-conjugate | Oct 18, 2006 | Abandoned |